Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in skin gene therapy.

W Pfützner1, J C Vogel

  • 1National Institute of Health, Dermatology Branch, National Cancer Institute, 6130 Executive Blvd, Bethesda, MD 20892-1908, USA. pfutzner@box-p.nih.gov

Expert Opinion on Investigational Drugs
|November 4, 2000
PubMed
Summary

Skin gene therapy offers potential for treating various diseases by genetically modifying skin cells. Researchers are exploring efficient delivery methods and targeting strategies to overcome challenges for successful clinical applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful COVID-19 Vaccination of a Patient With Hypersensitivity to Polyethylene Glycol and Polysorbate.

Journal of investigational allergology & clinical immunology·2022
Same author

Phylloid hypermelanosis: further report of an unusual syndrome.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

[Allergen-specific immunotherapy].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2021
Same author

[Allergen immunotherapy: FAQs and facts].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2021
Same author

Immediate-Type Hypersensitivity to Polyethylene Glycol (PEG) and a PEG-Containing COVID-19 Vaccine Revealed by Intradermal Testing.

Journal of investigational allergology & clinical immunology·2021
Same author

Omalizumab response correlates with reduced IFN-γ-, IL-10- and IL-31-secreting cells in chronic spontaneous urticaria.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020

Area of Science:

  • Dermatology
  • Molecular Biology
  • Gene Therapy

Background:

  • The skin's unique properties make it a promising target for gene therapy.
  • Various skin cell types (keratinocytes, melanocytes, dendritic cells) can be genetically modified.
  • Gene therapy can address genetic skin disorders, cancers, metabolic, and infectious diseases.

Purpose of the Study:

  • To review recent advancements in cutaneous gene therapy.
  • To evaluate strategies for overcoming current challenges in the field.
  • To assess the potential for successful clinical applications of skin gene therapy.

Main Methods:

  • Review of current literature on skin gene therapy approaches.
  • Analysis of different gene delivery methods and their impact on efficiency and expression.
  • Evaluation of strategies for targeting specific epidermal cells, including stem cells.

Main Results:

  • The skin's accessibility allows for diverse gene delivery methods.
  • Gene delivery approaches influence DNA delivery efficiency, transgene expression levels, and duration.
  • Key challenges include optimizing in vivo delivery, cell targeting, and sustained/regulated gene expression.

Conclusions:

  • Advances in gene therapy offer significant potential for treating skin-related diseases.
  • Overcoming challenges in gene delivery efficiency, cell targeting, and expression control is crucial.
  • Further research and strategic development are needed for successful clinical translation of skin gene therapy.

Related Experiment Videos